13189-98-5 | (2R)-2-amino-3-[(3-hydroxypropyl)sulfanyl]propanoic acid

Packsize	Purity	Availability	Price	Discounted Price
50mg	98%	in stock	$6.00	$4.00
100mg	98%	in stock	$6.00	$4.00
1g	98%	in stock	$8.00	$5.00
5g	95%	in stock	$12.00	$9.00
100g	98%	in stock	$225.00	$157.00

Description

• Catalog Number: AA46299
• Chemical Name: (2R)-2-amino-3-[(3-hydroxypropyl)sulfanyl]propanoic acid
• CAS Number: 13189-98-5
• Molecular Formula: C6H13NO3S
• Molecular Weight: 179.2373
• MDL Number: MFCD00899873
• SMILES: OCCCSC[C@@H](C(=O)O)N

Computed Properties

• Complexity: 120
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 6
• XLogP3: -3

Literature

• Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine.

  Chest 20090601

• Effect of fudosteine on mucin production.

  The European respiratory journal 20081101

• The characterization of selected drugs with infrared laser desorption/tunable synchrotron vacuum ultraviolet photoionization mass spectrometry.

  Rapid communications in mass spectrometry : RCM 20080801

• High-throughput determination of fudosteine in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080501

• Quantification of fudosteine in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry employing precolumn derivatization with 9-fluorenylmethyl chloroformate.

  Journal of mass spectrometry : JMS 20060501

• The pharmacokinetics of orally administered fudosteine in healthy Chinese volunteers.

  European journal of drug metabolism and pharmacokinetics 20060101

• [Pharmacokinetics of fudosteine in healthy volunteers].

  Yao xue xue bao = Acta pharmaceutica Sinica 20051001

• Inhibition of endotoxin- and antigen-induced airway inflammation by fudosteine, a mucoactive agent.

  Pulmonary pharmacology & therapeutics 20050101

• Effect of fudosteine, a new cysteine derivative, on mucociliary transport.

  The Journal of pharmacy and pharmacology 20010601